RAPT Therapeutics, Inc. Marketable Securities (Current)
RAPT Therapeutics, Inc. had Marketable Securities (Current) of $119.41 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-11-06
- 2025-09-30: Marketable Securities, Current $119.41M.
- 2025-06-30: Marketable Securities, Current $127.06M.
- 2025-03-31: Marketable Securities, Current $119.02M.
- 2024-12-31: Marketable Securities, Current $61.32M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-09-30 | $119.41M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $127.06M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $119.02M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $61.32M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $60.01M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $77.76M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $96.26M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $111.38M 10-K · filed 2025-03-06 |
| 2023-09-30 | $130.64M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $154.83M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $185.86M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $210.12M 10-K · filed 2024-03-07 |
| 2022-09-30 | $167.73M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $150.14M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $140.59M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $165.63M 10-K · filed 2023-03-14 |
| 2021-09-30 | $150.79M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $137.08M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $73.69M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $86.59M 10-K · filed 2022-03-10 |
| 2020-09-30 | $102.56M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $103.99M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $46.67M 10-Q · filed 2020-05-14 |